ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

The scoring method, called the Tumor Immune Microenvironment Spatial System, or TIMES, is the first tool in the world to ...

Ovarian cancer is the deadliest form of gynecologic cancer, taking the lives of more than 13,000 women in the U.S. each year.

The following is a summary of "Nanobodies targeting the tumor microenvironment and their formulation as nanomedicines," ...

The following is a summary of "Lipid Metabolic Reprograming: the Unsung Hero in Breast Cancer Progression and Tumor ...

A new type of antibody which stimulates the immune system to target cancer cells slows tumour growth, according to new ...

Through a mouse study, scientists have found that aspirin may help prevent metastases, or secondary tumors, by boosting the ...

A new review article published in Genes & Diseases sheds light on the complex molecular mechanisms through which ...

This study shows that engineered E. coli Nissle 1917 producing indole-3-acetic acid (IAA), an AhR agonist, modulate the tumor ...

Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO.

The lab of Filippo Veglia, Ph.D., at The Wistar Institute has discovered a previously unknown mechanism for how aggressive ...